Skip to main content

Peer Review reports

From: Comparative efficacy, safety and cost of oral Chinese patent medicines for rheumatoid arthritis: a Bayesian network meta-analysis

Original Submission
22 Feb 2020 Submitted Original manuscript
22 Mar 2020 Reviewed Reviewer Report - Asser Sallam
31 Mar 2020 Reviewed Reviewer Report - Jingjie Yu
28 Apr 2020 Author responded Author comments - Dan Zhang
Resubmission - Version 2
28 Apr 2020 Submitted Manuscript version 2
18 May 2020 Reviewed Reviewer Report
19 May 2020 Reviewed Reviewer Report - Asser Sallam
12 Jun 2020 Author responded Author comments - Dan Zhang
Resubmission - Version 3
12 Jun 2020 Submitted Manuscript version 3
22 Jun 2020 Author responded Author comments - Dan Zhang
Resubmission - Version 4
22 Jun 2020 Submitted Manuscript version 4
Publishing
26 Jun 2020 Editorially accepted
6 Jul 2020 Article published 10.1186/s12906-020-03004-4

You can find further information about peer review here.

Back to article page